ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,143,000 | -2.1% | 68,130 | -4.8% | 1.07% | -9.7% |
| Q1 2018 | $1,168,000 | -19.0% | 71,594 | -36.5% | 1.19% | -17.8% |
| Q4 2017 | $1,442,000 | -2.0% | 112,662 | -5.8% | 1.44% | +7.1% |
| Q3 2017 | $1,471,000 | +45.2% | 119,579 | -1.2% | 1.35% | +48.6% |
| Q2 2017 | $1,013,000 | -8.2% | 121,074 | -1.9% | 0.91% | -15.9% |
| Q1 2017 | $1,104,000 | -42.9% | 123,467 | -43.9% | 1.08% | -47.1% |
| Q4 2016 | $1,933,000 | -13.0% | 219,926 | -33.2% | 2.04% | -7.1% |
| Q3 2016 | $2,223,000 | +73.3% | 329,282 | -8.6% | 2.20% | +222.1% |
| Q2 2016 | $1,283,000 | +16.3% | 360,282 | -3.6% | 0.68% | +13.3% |
| Q1 2016 | $1,103,000 | -30.6% | 373,857 | -0.7% | 0.60% | -22.9% |
| Q4 2015 | $1,589,000 | -8.7% | 376,477 | -1.4% | 0.78% | -16.6% |
| Q3 2015 | $1,741,000 | -37.0% | 381,777 | -0.3% | 0.94% | -23.9% |
| Q2 2015 | $2,762,000 | -1.7% | 383,022 | +0.5% | 1.23% | -1.0% |
| Q1 2015 | $2,809,000 | -1.0% | 381,197 | -36.5% | 1.24% | -8.9% |
| Q4 2014 | $2,838,000 | -60.4% | 600,057 | -70.1% | 1.36% | -61.5% |
| Q3 2014 | $7,160,000 | -22.0% | 2,005,410 | -0.3% | 3.54% | -15.9% |
| Q2 2014 | $9,174,000 | -11.3% | 2,011,900 | -8.6% | 4.22% | -2.9% |
| Q1 2014 | $10,346,000 | -7.3% | 2,201,265 | -1.2% | 4.34% | -14.1% |
| Q4 2013 | $11,165,000 | -36.1% | 2,228,628 | -20.6% | 5.05% | -21.3% |
| Q3 2013 | $17,470,000 | +7.3% | 2,808,537 | -21.7% | 6.42% | +0.9% |
| Q2 2013 | $16,286,000 | – | 3,587,128 | – | 6.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |